Dong Hyun Kim

14PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 31, 2026
Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01.

|Jun 24, 2026
Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

|Mar 22, 2026
Allogeneic hematopoietic stem cell transplantation following T-cell-directed immunotherapy failure in B-cell lymphoma: a real-world case series and systematic literature review.

Dong Hyun Kim, Seungah Cha, Youngil Koh

|Jan 15, 2026
Infections after bispecific antibodies in B-cell lymphomas.

Dong Hyun Kim, Naryllae Lee, Youngil Koh

|Dec 25, 2025
Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea.

Dong Hyun Kim, Soyean Kwon, Seungah Cha

|Dec 24, 2025
Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS, limited in AML.

Dong Hyun Kim, Sin Young Park, Hyunsoo Cho

Pageof 3

Frequent Collaborators

4 joint publications

Bhumsuk Keam

4 joint publications

Junshik Hong

4 joint publications

Ja Min Byun

4 joint publications

Youngil Koh